REALREAL INC/THE (REAL) Fundamental Analysis & Valuation

NASDAQ:REAL • US88339P1012

9.97 USD
-0.07 (-0.7%)
At close: Mar 12, 2026
9.87 USD
-0.1 (-1%)
Pre-Market: 3/13/2026, 4:38:19 AM

This REAL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to REAL. REAL was compared to 124 industry peers in the Specialty Retail industry. Both the profitability and financial health of REAL have multiple concerns. REAL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. REAL Profitability Analysis

1.1 Basic Checks

  • In the past year REAL has reported negative net income.
  • In the past year REAL had a positive cash flow from operations.
  • REAL had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: REAL reported negative operating cash flow in multiple years.
REAL Yearly Net Income VS EBIT VS OCF VS FCFREAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • REAL has a worse Return On Assets (-10.22%) than 72.58% of its industry peers.
Industry RankSector Rank
ROA -10.22%
ROE N/A
ROIC N/A
ROA(3y)-26.54%
ROA(5y)-28.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REAL Yearly ROA, ROE, ROICREAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K 1.5K

1.3 Margins

  • Looking at the Gross Margin, with a value of 74.59%, REAL belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
  • In the last couple of years the Gross Margin of REAL has grown nicely.
  • REAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.89%
GM growth 5Y3.58%
REAL Yearly Profit, Operating, Gross MarginsREAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

1

2. REAL Health Analysis

2.1 Basic Checks

  • REAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for REAL has been increased compared to 1 year ago.
  • Compared to 5 years ago, REAL has more shares outstanding
  • Compared to 1 year ago, REAL has an improved debt to assets ratio.
REAL Yearly Shares OutstandingREAL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
REAL Yearly Total Debt VS Total AssetsREAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • REAL has an Altman-Z score of -2.18. This is a bad value and indicates that REAL is not financially healthy and even has some risk of bankruptcy.
  • REAL has a Altman-Z score of -2.18. This is amonst the worse of the industry: REAL underperforms 83.87% of its industry peers.
  • The Debt to FCF ratio of REAL is 67.89, which is on the high side as it means it would take REAL, 67.89 years of fcf income to pay off all of its debts.
  • REAL has a Debt to FCF ratio of 67.89. This is comparable to the rest of the industry: REAL outperforms 43.55% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 67.89
Altman-Z -2.18
ROIC/WACCN/A
WACC9.26%
REAL Yearly LT Debt VS Equity VS FCFREAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that REAL may have some problems paying its short term obligations.
  • REAL's Current ratio of 0.86 is on the low side compared to the rest of the industry. REAL is outperformed by 79.84% of its industry peers.
  • REAL has a Quick Ratio of 0.86. This is a bad value and indicates that REAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • REAL has a better Quick ratio (0.74) than 63.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.74
REAL Yearly Current Assets VS Current LiabilitesREAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

5

3. REAL Growth Analysis

3.1 Past

  • REAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.71%, which is quite impressive.
  • Looking at the last year, REAL shows a quite strong growth in Revenue. The Revenue has grown by 15.38% in the last year.
  • Measured over the past years, REAL shows a quite strong growth in Revenue. The Revenue has been growing by 18.23% on average per year.
EPS 1Y (TTM)65.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)15.38%
Revenue growth 3Y4.71%
Revenue growth 5Y18.23%
Sales Q2Q%18.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 68.25% on average over the next years. This is a very strong growth
  • REAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.04% yearly.
EPS Next Y131.57%
EPS Next 2Y95.28%
EPS Next 3Y68.25%
EPS Next 5YN/A
Revenue Next Year12.61%
Revenue Next 2Y11.39%
Revenue Next 3Y10.31%
Revenue Next 5Y13.04%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
REAL Yearly Revenue VS EstimatesREAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B
REAL Yearly EPS VS EstimatesREAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5

2

4. REAL Valuation Analysis

4.1 Price/Earnings Ratio

  • REAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • REAL is valuated quite expensively with a Price/Forward Earnings ratio of 263.18.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of REAL is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, REAL is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 263.18
REAL Price Earnings VS Forward Price EarningsREAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, REAL is valued a bit more expensive than the industry average as 68.55% of the companies are valued more cheaply.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as REAL.
Industry RankSector Rank
P/FCF 216.58
EV/EBITDA 155.11
REAL Per share dataREAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates REAL does not grow enough to justify the current Price/Earnings ratio.
  • REAL's earnings are expected to grow with 68.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y95.28%
EPS Next 3Y68.25%

0

5. REAL Dividend Analysis

5.1 Amount

  • REAL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

REAL Fundamentals: All Metrics, Ratios and Statistics

REALREAL INC/THE

NASDAQ:REAL (3/12/2026, 8:08:04 PM)

Premarket: 9.87 -0.1 (-1%)

9.97

-0.07 (-0.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners99.34%
Inst Owner Change13.82%
Ins Owners9.09%
Ins Owner Change-1.63%
Market Cap1.19B
Revenue(TTM)692.85M
Net Income(TTM)-41.80M
Analysts81.33
Price Target18.36 (84.15%)
Short Float %18.59%
Short Ratio6.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.88%
Min EPS beat(2)31.37%
Max EPS beat(2)58.38%
EPS beat(4)4
Avg EPS beat(4)31.45%
Min EPS beat(4)6.63%
Max EPS beat(4)58.38%
EPS beat(8)8
Avg EPS beat(8)27.21%
EPS beat(12)12
Avg EPS beat(12)27.83%
EPS beat(16)16
Avg EPS beat(16)24.29%
Revenue beat(2)0
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)-0.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)1.41%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)-0.07%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)0%
PT rev (3m)19.01%
EPS NQ rev (1m)42.02%
EPS NQ rev (3m)37.25%
EPS NY rev (1m)73.31%
EPS NY rev (3m)642.8%
Revenue NQ rev (1m)3.31%
Revenue NQ rev (3m)4.72%
Revenue NY rev (1m)1.56%
Revenue NY rev (3m)1.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 263.18
P/S 1.71
P/FCF 216.58
P/OCF 32.05
P/B N/A
P/tB N/A
EV/EBITDA 155.11
EPS(TTM)-0.12
EYN/A
EPS(NY)0.04
Fwd EY0.38%
FCF(TTM)0.05
FCFY0.46%
OCF(TTM)0.31
OCFY3.12%
SpS5.82
BVpS-3.49
TBVpS-3.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.59%
FCFM 0.79%
ROA(3y)-26.54%
ROA(5y)-28.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.89%
GM growth 5Y3.58%
F-Score6
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 67.89
Debt/EBITDA 40.99
Cap/Depr 95.54%
Cap/Sales 4.55%
Interest Coverage N/A
Cash Conversion 408.05%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.74
Altman-Z -2.18
F-Score6
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)102.39%
Cap/Depr(5y)128.44%
Cap/Sales(3y)5.52%
Cap/Sales(5y)6.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next Y131.57%
EPS Next 2Y95.28%
EPS Next 3Y68.25%
EPS Next 5YN/A
Revenue 1Y (TTM)15.38%
Revenue growth 3Y4.71%
Revenue growth 5Y18.23%
Sales Q2Q%18.33%
Revenue Next Year12.61%
Revenue Next 2Y11.39%
Revenue Next 3Y10.31%
Revenue Next 5Y13.04%
EBIT growth 1Y57.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year326.08%
EBIT Next 3Y80.93%
EBIT Next 5Y48.2%
FCF growth 1Y586.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.86%
OCF growth 3YN/A
OCF growth 5YN/A

REALREAL INC/THE / REAL FAQ

What is the ChartMill fundamental rating of REALREAL INC/THE (REAL) stock?

ChartMill assigns a fundamental rating of 2 / 10 to REAL.


What is the valuation status of REALREAL INC/THE (REAL) stock?

ChartMill assigns a valuation rating of 2 / 10 to REALREAL INC/THE (REAL). This can be considered as Overvalued.


How profitable is REALREAL INC/THE (REAL) stock?

REALREAL INC/THE (REAL) has a profitability rating of 2 / 10.


Can you provide the financial health for REAL stock?

The financial health rating of REALREAL INC/THE (REAL) is 1 / 10.


What is the earnings growth outlook for REALREAL INC/THE?

The Earnings per Share (EPS) of REALREAL INC/THE (REAL) is expected to grow by 131.57% in the next year.